Spondyloepiphyseal dysplasia is a rare hereditary disorder characterized by growth deficiency, spinal malformations, and, in some cases, ocular abnormalities.
Spondyloepiphyseal dysplasia is one of the most common causes of short stature. There are two forms of spondyloepiphyseal dysplasia. Both forms are inherited and both forms are rare.
Treatment is mostly symptomatic, and may include:
Individuals with congenital spondyloepiphyseal dysplasia should be closely monitored during anesthesia and for complications during a respiratory infection. In particular, during anesthesia, special attention is required to avoid spinal injury resulting from lax ligaments causing instability in the neck. This condition may also result in spinal injury in contact sports and car accidents. Chest constriction may also cause decreased lung capacity.
Treatment is mostly symptomatic, and may include:
Some individuals with short stature resulting from spondyloepiphyseal dysplasia may consider limb-lengthening surgery. This is a controversial surgery that lengthens leg and arm bones by cutting the bones, constructing metal frames around them, and inserting pins into them to move the cut ends apart. New bone tissue fills in the gap. While the surgery can be effective in lengthening limbs, various complications may occur.
Both forms of the disorder are inherited, however they are inherited differently.
It has been estimated that spondyloepiphyseal dysplasia affects about one in 100,000 individuals.
Congenital spondyloepiphyseal dysplasia affects both males and females. Spondyloepiphyseal dysplasia tarda affects mostly males.
X rays may be used to diagnose spondyloepiphyseal dysplasia when it is suspected.
Genetic counseling may be of benefit for patients and their families.
In congenital spondyloepiphyseal dysplasia, only one parent needs to be a carrier in order for the child to inherit the disorder. A child has a 50% chance of having the disorder if one parent has the disorder and a 75% chance of having the disease if both parents have congenital spondyloepiphyseal dysplasia.
In spondyloepiphyseal dysplasia tarda, if a mother has a male child, he has a 50% chance of inheriting the disease-causing gene. A male who inherits an X-linked recessive disorder is affected, and all of his daughters will be carriers, but none of his sons.
Prenatal testing may be available to couples at risk for bearing a child with spondyloepiphyseal dysplasia. Testing for the genes responsible for congenital spondyloepiphyseal dysplasia and spondyloepiphyseal dysplasia tarda is possible. Congenital spondyloepiphyseal dysplasia testing may be difficult, however, since although the gene has been located, there is variability in the mutations in the gene amongst persons with the disorder.
Either chorionic villus sampling (CVS) or amniocentesis may be performed for prenatal testing. CVS is a procedure to obtain chorionic villi tissue for testing. Examination of fetal tissue can reveal information about the defects that lead to spondyloepiphyseal dysplasia. Chorionic villus sampling can be performed at 10–12 weeks gestation.
Amniocentesis is a procedure that involves inserting a thin needle into the uterus, into the amniotic sac, and withdrawing a small amount of amniotic fluid. DNA can be extracted from the fetal cells contained in the amniotic fluid and tested. Amniocentesis is performed at 16–18 weeks gestation.
Individuals with spondyloepiphyseal dysplasia should be under routine health supervision by a physician who is familiar with the disorder, its complications, and its treatment.
Prognosis is variable dependent upon severity of the disorder. Generally, congenital spondyloepiphyseal dysplasia is more symptomatic than spondyloepiphyseal dysplasia tarda. Neither form of the disorder generally leads to shortened life span. Cognitive function is generally normal.
Medical Genetics, edited by Lynn B. Jorde, et al. 2nd ed. St. Louis: Mosby, 1999.
Gecz, J., et al. "Gene Structure and Expression Study of the SEDL Gene for Spondyloepiphyseal Dysplasia Tarda." Genomics 69 (2000): 242-51.
Gedeon, A.K., et al. "Identification of the Gene (SEDL) Causing X-linked Spondyloepiphyseal Dysplasia Tarda." Nature Genetics 22 (1999): 400-404.
Human Growth Foundation. 997 Glen Cove Ave., Glen Head, NY 11545. (800) 451-6434. Fax: (516) 671-4055. <http://www.hgf1@hgfound.org>.
Little People of America, Inc. National Headquarters, PO Box 745, Lubbock, TX 79408. (806) 737-8186 or (888) LPA-2001. lpadatabase@juno.com. <http://www.lpaonline.org>.
Little People's Research Fund, Inc. 80 Sister Pierre Dr., Towson, MD 21204-7534. (410) 494-0055 or (800) 232-5773. Fax: (410) 494-0062. <http://pixelscapes.com/lprf>.
MAGIC Foundation for Children's Growth. 1327 N. Harlem Ave., Oak Park, IL 60302. (708) 383-0808 or (800) 362-4423. Fax: (708) 383-0899. mary@magicfoundation.org. <http://www.magicfoundation.org/ghd.html>.
Short Stature Foundation. 4521 Campus Drive, #310, Irvine, CA 92715. (714) 559-7131 or (800) 243-9273.
OMIM—Online Mendelian Inheritance in Man. <http://www.ncbi.nlm.nih.gov/Omim/searchomim.html>.
Jennifer F. Wilson, MS